Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 975 of 1329 entries
View as:

Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01476410 Org: User:
Start: 11/30/11 End: 05/31/21 Due: 05/31/22

Ramelteon for Insomnia Comorbid With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00869167 Org: User:
Start: 03/31/08 End: 06/30/09 Due: 06/30/10

Serum Sex Hormone Levels and Subclinical Atherosclerosis - Ancillary to MESA

Phase: N/A Priority: Normal
NCT ID: NCT00064532 Org: User:
Start: 07/31/03 End: 06/30/08 Due: 06/30/09

Neural and Visual Responses to Light in Bipolar Disorder: A Novel Putative Biomarker

Phase: N/A Priority: Normal
NCT ID: NCT02048995 Org: User:
Start: 02/28/14 End: 12/31/17 Due: 12/31/18

Serotonin 1A Agonists and Cognition in Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00178971 Org: User:
Start: 01/31/03 End: 10/31/04 Due: 10/31/05

Proteogenomic Monitoring and Assessment of Kidney Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT01531257 Org: User:
Start: 04/30/10 End: 12/31/26 Due: 12/31/27

Mapping Corticoreticulospinal Motor Control in Chronic Hemiparetic Stroke

Phase: N/A Priority: Normal
NCT ID: NCT06598150 Org: User:
Start: 01/10/25 End: 08/31/26 Due: 08/31/27

Development and Evaluation of an Electronic Health Record-based Medication Complete Communication (EMC2) Strategy

Phase: N/A Priority: Normal
NCT ID: NCT03652272 Org: User:
Start: 02/08/19 End: 09/27/21 Due: 09/27/22

Denosumab in Treating Patients With ER and/or PR Positive, HER2 Negative Metastatic Breast Cancer With Bone Metastases and Detectable Circulating Tumor Cells

Phase: N/A Priority: Normal
NCT ID: NCT03070002 Org: User:
Start: 10/19/17 End: 04/24/18 Due: 04/24/19

Liver Cirrhosis Network Cohort Study

Phase: N/A Priority: Normal
NCT ID: NCT05740358 Org: User:
Start: 11/18/22 End: 07/25/28 Due: 07/25/29

Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia Using Patient-Reported Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT05898932 Org: User:
Start: 06/01/23 End: 08/31/26 Due: 08/31/27

Project 1 Aim 2, Adaptations of the Brain in Chronic Pain With Opioid Exposure

Phase: N/A Priority: Normal
NCT ID: NCT05463367 Org: User:
Start: 01/01/21 End: 06/01/25 Due: 06/01/26

Study of the Carbon Dioxide Treatment for Fat Reduction

Phase: N/A Priority: Normal
NCT ID: NCT00974415 Org: User:
Start: 01/31/10 End: 12/31/25 Due: 12/31/26

Promotora-Led Intervention for Metabolic and Mental Health

Phase: N/A Priority: Normal
NCT ID: NCT03372018 Org: User:
Start: 08/07/18 End: 03/22/19 Due: 03/22/20

Improvement of Hyperglycemia/Diabetes in Patients to Improve Safety

Phase: N/A Priority: Normal
NCT ID: NCT06096311 Org: User:
Start: 04/01/22 End: 12/01/25 Due: 12/01/26

Vitamin D for Women at Increased Risk of Developing Ovarian, Fallopian, or Primary Peritoneal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01744821 Org: User:
Start: 10/31/12 End: 04/30/15 Due: 04/30/16

Quality of Life in Patients Undergoing Embolization Using Yttrium Y 90 Glass Microspheres for Primary or Metastatic Liver Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00739167 Org: User:
Start: 04/30/08 End: 05/31/10 Due: 05/31/11

Evaluation of Perioperative Celecoxib for Hip Arthroscopy

Phase: N/A Priority: Normal
NCT ID: NCT02779166 Org: User:
Start: 08/31/12 End: 05/31/16 Due: 05/31/17

PROphylactic Manual RotatIon in the Second stagE of Labor

Phase: N/A Priority: Normal
NCT ID: NCT05175040 Org: User:
Start: 03/04/22 End: 12/15/23 Due: 12/15/24

Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00940316 Org: User:
Start: 01/18/10 End: 01/31/15 Due: 01/31/16

The Effect of Magnesium on Maternal Mood, Cognitive Function, and Birth Experience

Phase: N/A Priority: Normal
NCT ID: NCT02454322 Org: User:
Start: 05/31/15 End: 12/31/21 Due: 12/31/22

HepQuant to Predict Hepatic Encephalopathy After TIPS

Phase: N/A Priority: Normal
NCT ID: NCT04664621 Org: User:
Start: 02/25/20 End: 09/30/21 Due: 09/30/22

Development of Dermatology-related Quality of Life Assessment in Patients Treated With Epidermal Growth Factor Receptor (EGFR) Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT01015326 Org: User:
Start: 07/31/06 End: 11/30/09 Due: 11/30/10

Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01372579 Org: User:
Start: 08/31/11 End: 06/30/21 Due: 06/30/22

Reduction of IgE Antibody in Human Allergic Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01280149 Org: User:
Start: 01/31/11 End: 06/20/17 Due: 06/20/18